Whether this finding is due to a technical advantage of the single-cell FISH or whether HER2 alterations might be truly driver enriched in NAFLD associated HCC requires further analysis. This evidence concerns the gene ERBB2 and metabolic dysfunction-associated steatotic liver disease.